J&J Suppressed Sales Of Cancer Test: Suit

Law360, New York (July 7, 2011, 3:48 PM EDT) -- Fearful of drawing attention to suspected links between Listerine and oral cancer, Johnson & Johnson ordered a subsidiary to break a contract to market an oral cancer test in the U.S., a $210 million lawsuit filed Wednesday in New Jersey claims.

Oral Cancer Prevention Inc., which brought the suit, said that its OralCDx cancer test could have prevented 7,300 cases of cancer in the U.S. if J&J had let subsidiary OraPhrama Inc. sell the device as it had promised. J&J, though, was worried its widespread marketing...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.